Home
About
Publications Trends
Recent Publications
Expert Search
Archive
humoral hypercalcemia of malignancy (hhm)
What Causes HHM?
The primary cause of HHM is the
secretion of parathyroid hormone-related protein (PTHrP)
by the tumor cells. PTHrP mimics the action of parathyroid hormone, leading to increased bone resorption and renal tubular calcium reabsorption, which results in elevated blood calcium levels. Other factors that can contribute include increased production of
Vitamin D analogs
by lymphomas and the direct
osteolytic activity of bone metastases
.
Frequently asked queries:
What is HHM?
What Causes HHM?
What are the Symptoms of HHM?
How is HHM Diagnosed?
What are the Treatment Options for HHM?
What is the Prognosis for Patients with HHM?
How Can HHM be Prevented?
How Can Patients and Families Facilitate Care Coordination?
What are Some Techniques to Handle MNAR?
How Can Patients Access Reliable Information?
What Does the Unconscious Mean in the Context of Cancer?
What are the Treatment Options for Neutropenia?
What is Hypocalcemia?
How Does Histological Grade Affect Prognosis?
What Role Do Carcinogens Play?
How Can Appetite Changes Be Managed?
How Often Should One Get a Colonoscopy?
Why is Interdisciplinary Coordination Important?
What Are the Common Types of Cancer Email Scams?
Why is Sperm Preparation Important for Cancer Patients?
Top Searches
Brain Tumor
Breast cancer
cancer
Cancer Diagnostics
Cancer Genomics
Chemotherapy
Essential Thrombocythemia
hepatocellular carcinoma
Lung Cancer
Molecular Biomarkers
Nanotechnology
Non-Hodgkin’s Lymphoma
Radiation-Induced Malignancies
Follow Us
Facebook
Linkedin
Youtube
Instagram
Partnered Content Networks
Relevant Topics
4D Segmentation
Alopecia
Atlas-based Segmentation
Automated Segmentation
B-cell malignancies
biomarkers
Brain Tumor
Brain Tumor Segmentation
Breast cancer
CALR Mutation
cancer
cancer diagnosis
Cancer Genome Atlas
Cancer genomics
Cancer treatment
CAR T-cell therapy
Carcinogenesis
cell adhesion
cell migration
cell-free RNA
chemotherapy
Chromatin remodeling genes
Chronic inflammation
CIAbimatoprost
circulating tumor cells
circulating tumor DNA
Clonal Expansion
Co-morbidity
Combination therapy
Copy number variations
cytokine release syndrome
Cytoreductive Therapyexpansion
Deep Learning
Diagnosis challenges
diffuse large B-cell lymphoma
DNA damage
docetaxel-cyclophosphamide
Drug delivery
early detection
epirubicin-cyclophosphamide
Essential Thrombocythemia
exosomes
extracellular matrix
Fibrosis
Genetic alteration
Glioblastoma
Gold nanoparticles
Hepatocellular carcinoma
High Tumor
image-guided radiotherapy
Imaging Techniques
Immunosuppression
Immunotherapy
Integrative genomics
integrin inhibitors
Integrins
intensity-modulated radiation therapy
JAK2 Mutation
Keratinocyte
Lipid-based nanoparticles
Liquid Biopsies
Liquid biopsy
liver cancer
long-term cancer risks
Lung cancer
Machine Learning
Magnetic Resonance Imaging
Megakaryocytes
metastasis
methyltransferase
minimal residual disease
Molecular Biomarkers
MPL Mutation
MRI
Multi-modal Imaging
Multidisciplinary care
Mutual exclusivity analysis
Myeloproliferative Neoplasm
Nanoparticles
Nanotechnology
neoadjuvant radiotherapy
neurotoxicity
Next-generation sequencing
nnovative Biomarkers
Non-Hodgkin’s lymphoma
non-invasive diagnostics
Novel Biomarkers for Brain Tumors
Novel Chemotherapy
Oncogenic transcription factors
oncological diseases
paclitaxel
Personalized medicine
Personalized Treatment
Photobiomodulation therapy
Platelets
Polymeric nanoparticles
portal vein tumor thrombus
precision medicine
Precision Oncology
Predictive Biomarkers
Probabilistic Models
proton therapy
Radiation-induced malignancies
radiotherapy
refractory lymphoma
relapsed lymphoma
Resistance Mechanisms
Risk factors
secondary cancer prevention
secondary cancers
Silver nanoparticles
stereotactic body radiation therapy
Targeted Therapies
Targeted therapy
Thrombosis
Tolerability
transarterial chemoembolization
Tuberculosis
tumor microenvironment
tumor progression
Tumor-Agnostic Treatments
Voltage-gated sodium channels
Subscribe to our Newsletter
Stay updated with our latest news and offers related to Cancer.
Subscribe